KIM, DAVID M.D.
Ophthalmology · NPI 1972763530 · UNION, NJ
KIM, DAVID is a Ophthalmology in UNION, NJ, a member of 1 medical group, who billed 19 distinct codes to Medicare Part B in 2024.
Groups: ASSOCIATED RETINAL CONSULTANTS LLC (TEANECK, NJ)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | premium | premium | premium | premium |
| J0177 | Injection, aflibercept hd, 1 mg | premium | premium | premium | premium |
| 92134 | Imaging of retina | premium | premium | premium | premium |
| 92014 | Established patient complete exam of visual system | premium | premium | premium | premium |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | premium | premium | premium | premium |
| 67028 | Injection of drug into eye | premium | premium | premium | premium |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | premium | premium | premium | premium |
| J0178 | Injection, aflibercept, 1 mg | premium | premium | premium | premium |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | premium | premium | premium | premium |
| J3590 | Unclassified biologics | premium | premium | premium | premium |
| 92201 | Extended exam of the back part of the eye with retinal drawing | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| 92012 | Established patient problem focused exam of visual system | premium | premium | premium | premium |
| 92250 | Photography of the retina | premium | premium | premium | premium |
| J7999 | Compounded drug, not otherwise classified | premium | premium | premium | premium |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| 76512 | 2d ultrasound scan of eye tissue and structures | premium | premium | premium | premium |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.